Abstract
Tapered titanium porous plasma-sprayed components have performed well in primary THA. To confirm the literature at longer followup we retrospectively reviewed all 1639 patients who underwent 2000 THAs in which a specific porous femoral component was used. One hundred fourteen patients (134 hips) were lost to followup leaving a cohort of 1525 patients (1866 THAs). The component is a tapered titanium plasma spray-coated design that remained relatively unchanged since its first implantation except for circumferential proximal porous coating added in 1986 and an offset option added in 1999. Minimum followup was 24 months (average, 119 months; range, 24 to 275 months). To date there have been 39 femoral revisions for an implant survival of 98%. Using the Kaplan-Meier method, cumulative survival with any stem revision as the end point was 98.6% at 5 years, 98.4% at 10 years, 97.1% at 15 years, and 95.5% at 20 years. Using aseptic revision for failure of ingrowth as the endpoint, stem survival was 99.1%. Kaplan-Meier cumulative survival with aseptic revision for failure of ingrowth as the endpoint was 99.4% at 5 years, 99.3% at 10, 15 and 20 years. Harris hip pain and total scores improved. This titanium, porous plasma spray-coated femoral component continues to demonstrate high long-term survival with a low rate of component revision for any reason or aseptic failure of ingrowth.
Level of Evidence: Level IV, therapeutic study (case series). See the Guidelines for Authors for a complete description of levels of evidence.
Similar content being viewed by others
References
American Academy of Orthopaedic Surgeons. Osteoarthritis of the hip: Hip joint replacement. Available at: http://www.aaos.org/Research/documents/OAinfo_hip_jointrepl.pdf. Accessed June 11, 2008.
Berend KR, Lombardi AV Jr, Mallory TH, Chonko DJ, Dodds KL, Adams JB. Cerclage wires or cables for the management of intraoperative fracture associated with a cementless, tapered femoral prosthesis: results at 2 to 16 years. J Arthroplasty. 2004; 19(7 Suppl 2):17–21.
Berend KR, Lombardi AV, Mallory TH, Dodds KL, Adams JB. Cementless double-tapered total hip arthroplasty in patients 75 years of age and older. J Arthroplasty. 2004;19:288–295.
Berend KR, Mallory TH, Lombardi AV Jr, Dodds KL, Adams JB. Tapered cementless femoral stem: difficult to place in varus but performs well in those rare cases. Orthopedics. 2007;30:295–297.
Bobyn JD, Jacobs JJ, Tanzer M, Urban RM, Aribindi R, Sumner DR, Turner TM, Brooks CE. The susceptibility of smooth implant surfaces to periimplant fibrosis and migration of polyethylene wear debris. Clin Orthop Relat Res. 1995;311:21–39.
Bobyn JD, Tanzer M, Krygier JJ, Dujovne AR, Brooks CE. Concerns with modularity in total hip arthroplasty. Clin Orthop Relat Res. 1994;298:27–36.
Bourne RB, Rorabeck CH, Patterson JJ, Guerin J. The proximal porous coating alternative for primary total hip arthroplasty. Clin Orthop Relat Res. 2001;393:112–120.
Callaghan JJ, Mallory TH. Optimal fixation for femoral components: cemented or cementless. J Arthroplasty. 1995;10:401–404.
Cameron HU, Keppler L, McTighe T. The role of modularity in primary total hip arthroplasty. J Arthroplasty. 2006;21(4 Suppl 1):89–92.
Christie MJ, DeBoer DK, Trick LW, Brothers JC, Jones RE, Vise GT, Gruen TA. Primary total hip arthroplasty with use of the modular S-ROM prosthesis. Four to seven-year clinical and radiographic results. J Bone Joint Surg Am. 1999;81:1707–716.
DeLee JG, Charnley J. Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res. 1976;121:20–32.
Dorr LD, Faugere MC, Mackel AM, Gruen TA, Bognar B, Malluche HH. Structural and cellular assessment of bone quality of proximal femur. Bone. 1993;14:231–242.
Dowdy PA, Rorabeck CH, Bourne RB. Uncemented total hip arthroplasty in patients 50 years of age or younger. J Arthroplasty. 1997;12:853–862.
Ellison B, Berend KR, Lombardi AV Jr, Mallory TH. Tapered titanium porous plasma-sprayed femoral component in patients aged 40 years and younger. J Arthroplasty. 2006;21(6 Suppl 2):32–37.
Emerson RH Jr, Head WC, Emerson CB, Rosenfeldt W, Higgins LL. A comparison of cemented and cementless titanium femoral components used for primary total hip arthroplasty: a radiographic and survivorship study. J Arthroplasty. 2002;17:584–591.
Emerson RH Jr, Head WC, Higgins LL. Clinical and radiographic analysis of the Mallory-Head femoral component in revision total hip arthroplasty. A minimum 8.8-year and average eleven-year follow-up study. J Bone Joint Surg Am. 2003;85:1921–1926.
Emerson RH Jr, Sanders SB, Head WC, Higgins L. Effect of circumferential plasma-spray porous coating on the rate of femoral osteolysis after total hip arthroplasty. J Bone Joint Surg Am. 1999;81:1291–1298.
Engh CA, Hopper RH Jr. The odyssey of porous-coated fixation. J Arthroplasty. 2002;17(4 Suppl 1):102–107.
Engh CA Jr, Claus AM, Hopper RH Jr, Engh CA. Long-term results using the anatomic medullary locking hip prosthesis. Clin Orthop Relat Res. 2001;393:137–146.
Eskelinen A, Remes V, Helenius I, Pulkkinen P, Nevalainen J, Paavolainen P. Uncemented total hip arthroplasty for primary osteoarthritis in young patients: a mid-to long-term follow-up study from the Finnish Arthroplasty Register. Acta Orthop. 2006;77:57–70.
Frndak PA, Mallory TH, Lombardi AV Jr: Translateral surgical approach to the hip: The abductor muscle “split”. Clin Orthop Relat Res. 1993;295:135–141.
Gosens T, van Langelaan EJ, Tonino AJ. Cementless mallory-head HA-coated hip arthroplasty for osteoarthritis in hip dysplasia. J Arthroplasty. 2003;18:401–410.
Harris M, Dorr LD, Wan Z, Sirianni L, Boutary M. Total hip arthroplasty with the APR stem and cup. Follow-up of a previous report. J Arthroplasty. 2005;20:828–831.
Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51:737–755.
Havelin LI, Engesaeter LB, Espehaug B, Furnes O, Lie SA, Vollset SE. The Norwegian arthroplasty register. 11 years and 73,000 arthroplasties. Acta Orthop Scand. 2000;71:337–353.
Head WC, Mallory TH, Emerson RH Jr. The proximal porous coating alternative for primary total hip arthroplasty. Orthopedics. 1999;22:813–815.
Hozack WJ, Rothman RH, Eng K, Mesa J. Primary cementless hip arthroplasty with a titanium plasma sprayed prosthesis. Clin Orthop Relat Res. 1996;333:217–225.
Joshi AB, Gill GS, Smith PL. Outcome in patients lost to follow-up. J Arthroplasty. 2003;18:149–153.
Kaplan EL, Meier P. Nonparametric estimation from incomplete data. J Am Statistical Assoc 1958;53:457–481.
Keisu KS, Orozco F, McCallum JD 3rd, Bissett G, Hozack WJ, Sharkey PF, Rothman RH. Cementless femoral fixation in the rheumatoid patient undergoing total hip arthroplasty: minimum 5-year results. J Arthroplasty. 2001;16:415–421.
Keisu KS, Orozco F, Sharkey PF, Hozack WJ, Rothman RH, McGuigan FX. Primary cementless total hip arthroplasty in octogenarians. Two to eleven-year follow-up. J Bone Joint Surg Am. 2001;83:359–363.
Khalily C, Lester DK. Results of a tapered cementless femoral stem implanted in varus. J Arthroplasty. 2002;17:463–466.
Kim YH. Long-term results of the cementless porous-coated anatomic total hip prosthesis. J Bone Joint Surg Br. 2005;87:623–627.
Kim YH, Kim JS, Cho SH. Primary total hip arthroplasty with a cementless porous-coated anatomic total hip prosthesis: 10- to 12-year results of prospective and consecutive series. J Arthroplasty. 1999;14:538–548.
Kim YH, Kim JS, Cho SH. Primary total hip arthroplasty with the AML total hip prosthesis. Clin Orthop Relat Res. 1999;360:147–158.
King PJ, Malin AS, Scott RD, Thornhill TS. The fate of patients not returning for follow-up five years after total knee arthroplasty. J Bone Joint Surg Am. 2004;86:897–901.
Kyle RF, Crickard GE. Hip arthroplasty: management problems; periprosthetic fractures associated with total hip arthroplasty. Orthopedics. 1998;21:982–984.
Little BS, Wixson RL, Stulberg SD. Total hip arthroplasty with the porous-coated anatomic hip prosthesis: results at 11 to 18 years. J Arthoplasty. 2006;21:338–343.
Lombardi AV Jr, Berend KR, Mallory TH. Hydroxyapatite-coated titanium porous plasma spray tapered stem: Experience at 15–18 years. Clin Orthop Relat Res. 2006;453:81–85.
Lombardi AV Jr, Mallory TH, Fada RA, Adams JB. Stem modularity: rarely necessary in primary total hip arthroplasty. Orthopedics. 2002;25:1385–1387.
Lombardi AV Jr, Mallory TH, Vaughn BK, Drouillard P: Aseptic loosening in total hip arthroplasty secondary to osteolysis induced by wear debris from titanium alloy modular femoral heads. J Bone Joint Surg Am. 1989;71:1337–1342.
Malchau H, Herberts P, Eisler T, Garellick G, Söderman P. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am. 2002;84(Suppl 2):2–20.
Malik MHA, Gambhir AK, Bale L, Pradhan N, Porter ML. Primary total hip replacement: a comparison of a nationally agreed to best practice and current surgical technique as determined by the North West Regional Arthroplasty Register. Ann R Coll Surg Engl. 2004;86:113–118.
Mallory TH, Head WC, Lombardi AV Jr. Tapered design for the cementless total hip arthroplasty femoral component. Clin Orthop Relat Res. 1997;344:172–178.
Mallory TH, Head WC, Lombardi AV Jr, Emerson RH Jr, Eberle RW, Mitchell MB. Clinical and radiographic outcome of a cementless, titanium, plasma spray-coated total hip arthroplasty femoral component. Justification for continuance of use. J Arthroplasty. 1996;11:653–660.
Mallory TH, Lombardi AV Jr, Leith JR, Fujita H, Hartman JF, Capps SG, Kefauver CA, Adams JB, Vorys GC. Minimal 10-year results of a tapered cementless femoral component in total hip arthroplasty. J Arthroplasty. 2001;16(8 Suppl 1):49–54.
Mallory TH, Lombardi AV Jr, Leith JR, Fujita H, Hartman JF, Capps SG, Kefauver CA, Adams JB, Vorys GC. Why a taper? J Bone Joint Surg Am. 2002;84(Suppl 2):81–89.
McLaughlin JR, Lee KR. Total hip arthroplasty with an uncemented femoral component. Excellent results at ten-year follow-up. J Bone Joint Surg Br. 1997;79:900–907.
McLaughlin JR, Lee KR. Total hip arthroplasty in young patients. 8- to 13-year results using an uncemented stem. Clin Orthop Relat Res. 2000;373:153–163.
McLaughlin JR, Lee KR. The outcome of total hip replacement in obese and non-obese patients at 10- to 18-years. J Bone Joint Surg Br. 2006;88:1286–1292.
McLaughlin JR, Lee KR. Total hip arthroplasty with an uncemented tapered femoral component. J Bone Joint Surg Am. 2008;90:1290–1296.
Mendenhall S. Hospital resources and implant cost management—a 2006 update. Orthopedic Network News. 2007;18:13–19.
Mineo R, Berend KR, Mallory TH, Lombardi AV Jr. A lateralized tapered titanium cementless femoral component does not increase thigh or trochanteric pain. Surg Tech Int. 2007;16:210–214.
Morshed S, Bozic KJ, Ries MD, Malchau H, Colford JM Jr. Comparison of cemented and uncemented fixation in total hip replacement. A meta-analysis. Acta Orthop. 2007;78:315–326.
Park MS, Choi BW, Kim SJ, Park JH. Plasma spray-coated Ti femoral component for cementless total hip arthroplasty. J Arthroplasty. 2003;18:626–630.
Parvizi J, Keisu KS, Hozack WJ, Sharkey PF, Rothman RH. Primary total hip arthroplasty with an uncemented femoral component: a long-term study of the Taperloc stem. J Arthroplasty. 2004;19:151–156.
Purtill JJ, Rothman RH, Hozack WJ, Sharkey PF. Total hip arthroplasty using two different cementless tapered stems. Clin Orthop Relat Res. 2001;393:121–127.
Rao RR, Sharkey PF, Hozack WJ, Eng K, Rothman RH. Immediate weightbearing after uncemented total hip arthroplasty. Clin Orthop Relat Res. 1998;349:156–162.
Reis MD. Hip arthroplasty: management problems; periprosthetic fractures: early and late. Orthopedics. 1997;20:789–800.
Reitman RD, Emerson R, Higgins L, Head W. Thirteen year results of total hip arthroplasty using a tapered titanium femoral component inserted without cement in patients with type C bone. J Arthroplasty. 2003;18(7 Suppl 1):116–121.
Rorabeck CH, Bourne RB, Mulliken BD, Nayak N, Laupacis A, Tugwell P, Feeney D. Comparative results of cemented and cementless total hip arthroplasty. Clin Orthop Relat Res. 1996;325:330–344.
Sakalkale DP, Eng K, Hozack WJ, Rothman RH. Minimum 10-year results of a tapered cementless hip replacement. Clin Orthop Relat Res. 1999;362:138–144.
Saleh KJ, Mulhall KJ, Bershadsky B, Ghomrawi HM, White LE, Buyea CM, Krackow KA. Development and validation of a lower-extremity activity scale. Use for patients treated with revision total knee arthroplasty. J Bone Joint Surg Am. 2005;87:1985–1994.
Schmidt AH, Kyle RF. Periprosthetic fractures of the femur. Orthop Clin North Am. 2002;33:143–152.
Tanzer M, Chan S, Brooks CE, Bobyn JD. Primary cementless total hip arthroplasty using a modular femoral component: a minimum 6-year follow-up. J Arthroplasty. 2001;16(8 Suppl 1):64–70.
Tanzer M, Maloney WJ, Jasty M, Harris WH. The progression of femoral cortical osteolysis in association with total hip arthroplasty without cement. J Bone Joint Surg Am. 1992;74:404–410.
Urban RM, Jacobs JJ, Sumner DR, Peters CL, Voss FR, Galante JO. The bone-implant interface of femoral stems with non-circumferential porous coating. J Bone Joint Surg Am. 1996;78:1068–1081.
Wirz D, Daniels AU, Göpfert B, Morscher EW. Clinical development and current status: Europe. Orthop Clin N Am. 2005;36:63–73.
Xenos JS, Callaghan JJ, Heekin RD, Hopkinson WJ, Savory CG, Moore MS. The porous-coated anatomic total hip prosthesis, inserted without cement. A prospective study with a minimum of ten years of follow-up. J Bone Joint Surg Am. 1999;81:74–82.
Acknowledgments
We thank J. Brooke Harris and Tawnya L. Tucker, M.T., for their assistance in preparation of this manuscript. Cases included in this review include surgeries performed by Bradley K. Vaughn, MD, and Robert A. Fada, MD, during their associations with Joint Implant Surgeons, Inc.
Author information
Authors and Affiliations
Corresponding author
Additional information
One or more of the authors (AVL, KRB, THM) receive royalties and have consulting agreements with Biomet, Inc. (Warsaw, IN). Institutional financial support is received from Biomet, Inc. Foundation support has been received from Allergan, Biomet, Inc.; GlaxoSmithKline; Medtronics; Merck; Mount Carmel New Albany Surgical Hospital; Pivotal Research Solutions, Inc., Pozen and Tornier.
Each author certifies that his or her institution has approved the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
About this article
Cite this article
Lombardi, A.V., Berend, K.R., Mallory, T.H. et al. Survivorship of 2000 Tapered Titanium Porous Plasma-sprayed Femoral Components. Clin Orthop Relat Res 467, 146–154 (2009). https://doi.org/10.1007/s11999-008-0568-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-008-0568-x